SEOUL, Sept. 10 (Korea Bizwire) — There are currently no vaccines or set treatments for the Middle East Respiratory Syndrome (MERS), industry officials said Monday, as the country confirmed over the weekend its first case in some three years. Pharmaceutical officials said that local drugmakers, such as Ilyang Pharmaceutical Co. and Gene One Life Science [...]
PLYMOUTH MEETING, Pa., Sept. 5 (Korea Bizwire) — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today announced the dosing of the first subject with its vaccine to prevent infection from the deadly MERS virus (Middle East Respiratory Syndrome) in a Phase 1/2a study to evaluate INO-4700 (or GLS-5300). The trial is ongoing in South Korea sponsored [...]
PLYMOUTH MEETING, Pa., and SEOUL, Korea, Sept. 4 (Korea Bizwire) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and GeneOne Life Science (KSE: 011000) today announced they have dosed the first patient in a Phase 1 study designed to evaluate a preventive vaccine against hepatitis C infection. Recruitment has already begun in South Korea, where GeneOne is responsible [...]
LOWELL, Mass., Oct. 23 (Korea Bizwire) — Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the receipt of a $7.3 million contract from the Biomedical Advanced Research and Development Authority (BARDA) for the implementation of a rapid sterility test for vaccines. This awarded grant is part of [...]
SEOUL, Aug. 27 (Korea Bizwire) — South Korea’s animal quarantine agency said Sunday that is has acquired know-how to make its own bird flu vaccines. The Animal and Plant Quarantine Agency (APQA) said that it has developed candidate vaccine materials for its “antigen bank” that targets the H5N6 and H5N1 strains of avian influenza (AI). [...]
SEOUL, July 22 (Korea Bizwire) – Despite the blazing hot weather, pharmaceutical companies are gearing up to compete in the market for flu vaccines for the winter season, particularly tetravalent flu vaccines that are expected to hit the market this year. Tetravalent flu vaccines, which mark the next development step after trivalent flu vaccines, provide protection against [...]
SEOUL, Oct. 3 (Korea Bizwire) — Green Cross, a South Korean biopharmaceutical company, seems to surpass industry’s expectations in the global pharmaceutical market. The Seoul-based pharmaceutical company accelerates export of its not only medicines including vaccines and plasma-derivatives but also pharmaceutical plants to other countries. The volume of medicine exports accounted for 151.7 billion won, [...]